When Google turns on you, you know you are in trouble

For years CIRM and others in the stem cell community (hello Paul Knoepfler) have been warning people about the dangers of going to clinics offering unproven and unapproved stem cell therapies. Recently the drum beat of people and organizations coming out in support of that stand has grown louder and louder. Mainstream media – TV … Continue reading When Google turns on you, you know you are in trouble

Getting the inside scoop on the stem cell agency

There’s a wonderful moment at the end of the movie The Candidate (starring Robert Redford, 87% approval on Rotten Tomatoes!) about a modern political campaign for a US Senate seat. Redford (spoiler alert) plays a come-from-behind candidate and at the end when he wins he turns to his campaign manager and says “Now what?”. I … Continue reading Getting the inside scoop on the stem cell agency

How CIRM support helped a promising approach to type 1 diabetes get vital financial backing

The “Valley of Death” sounds like a scary place from “Lord of the Rings” or “Game of Thrones” that our heroes have to navigate to reach safety. The reality is not that different. It’s the space that young companies have to navigate from having a good idea to getting financial backing, so they can move … Continue reading How CIRM support helped a promising approach to type 1 diabetes get vital financial backing

How small talk led to a big break; a summer internship at CIRM

At CIRM, California's Stem Cell Agency, we are fortunate to work with some amazing people. This summer we added another name that list when Melissa Cairos joined us for an internship. Melissa is now on to the next part of her adventure, as a policy wonk in Washington DC., but before she left we asked … Continue reading How small talk led to a big break; a summer internship at CIRM

Has Regenerative Medicine Come of Age?

For the past few years the Signals blog site -  which offers an insiders’ perspectives on the world of regenerative medicine and stem cell research - has hosted what it calls a "Blog Carnival". This is an event where bloggers from across the stem cell field are invited to submit a piece based on a … Continue reading Has Regenerative Medicine Come of Age?

Regenerative Medicine by the numbers: a snapshot of how the field is progressing

Statistics don’t usually make for very exciting blog fodder, but they can be useful in charting progress. Case in point, the recent quarterly report from the Alliance for Regenerative Medicine (ARM), a global advocate and industry group for the field. In the report ARM takes an in-depth look at cell therapy, gene therapy, tissue engineering … Continue reading Regenerative Medicine by the numbers: a snapshot of how the field is progressing

CIRM-funded medical research and development company does $150M deal to improve care for dialysis patients

Nearly half a million Americans with kidney disease are on dialysis, so it’s not surprising the CIRM Board had no hesitation, back in July 2016, in funding a program to make it easier and safer to get that life-saving therapy. That's why it’s gratifying to now hear that Humacyte, the company behind this new dialysis … Continue reading CIRM-funded medical research and development company does $150M deal to improve care for dialysis patients

CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”

CIRM is commending the US Food and Drug Administration (FDA) for its action against two stem cell clinics offering unapproved therapies. On Wednesday, the FDA filed two complaints in federal court seeking a permanent injunction against California Stem Cell Treatment Center Inc. and US Stem Cell Clinic LLC. of Sunrise, Florida. The FDA says the … Continue reading CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”

CIRM’s Industry Alliance Program: Facilitating Partnerships to Advance Stem Cell Therapies

Some things are better together. Take for instance macaroni and cheese, eggs and bacon, cookies and ice cream. Each of these things are fine on their own, but together, they become something more powerful and delicious. The right partnerships can bring out the best in things. At CIRM, we fully embrace this concept. That’s why … Continue reading CIRM’s Industry Alliance Program: Facilitating Partnerships to Advance Stem Cell Therapies

If you’re into stem cell manufacturing, this is the conference for you!

Fulfilling CIRM’s mission doesn’t just mean accelerating promising stem cell treatments to patients. It also involves accelerating the whole field of regenerative medicine, which involves not just research, but developing candidate treatments, manufacturing cell therapies, and testing these therapies in clinical trials. Manufacturing and the pre-clinical safety evaluation of cell therapies are topics that don’t … Continue reading If you’re into stem cell manufacturing, this is the conference for you!